Revolution Medicines, Inc. (RVMD) Tops Q1 EPS by 5c
Tweet
Share
E-mailGet Alerts RVMD Hot Sheet
Join SI Premium – FREE
Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q1 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Revolution Medicines R&D chief to step down ahead of 2027 retirement
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
